Exosomes are involved in the intercellular transfer of rapamycin resistance in the breast cancer cells

Yuri Yu. Shchegolev ¹ , Danila V. Sorokin ¹, Alexander M. Scherbakov ¹ * , Olga E. Andreeva ¹ , Diana I. Salnikova ¹ , Ekaterina I. Mikhaevich ¹ , Margarita V. Gudkova ¹ , Mikhail A. Krasil’nikov ¹

Cited by CrossRef: 1

1- Andreeva O, Sorokin D, Vinokurova S, Shchegolev Y, Elkina N, Katargin A, Faskhutdinov R, Salnikova D, Scherbakov A, Krasil’nikov M. The effect of DNA methyltransferase 3A suppression in progression of the resistance phenotype in breast cancer cells. Usp mol onkol. 2023;10(4):149 [Crossref]

2- A, Alhuthali H, Alshehri J, Alkathiri A, Almaghrabi R, Alsaeed S, Albebi S, Almethn R, Alfuraydi B, Alharbi S, Kamal M, Imran M. Exosomes in infectious diseases: insights into leishmaniasis pathogenesis, immune modulation, and therapeutic potential. Naunyn-Schmiedeberg's Arch Pharmacol. 2024; [Crossref]

3- Graifer D, Malygin A, Shefer A, Tamkovich S. Ribosomal Proteins as Exosomal Cargo: Random Passengers or Crucial Players in Carcinogenesis?. Advanced Biology. 2025; [Crossref]

4- Andreeva O, Sorokin D, Vinokurova S, Kopnin P, Elkina N, Katargin A, Faskhutdinov R, Salnikova D, Scherbakov A, Krasil’nikov M. Breast cancer cell resistance to hormonal and targeted therapeutics is correlated with the inactivation of the NR6A1 axis. Cancer Drug Resist. 2024; [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons